New app helps prostate cancer patients decide on genetic testing

NCT ID NCT04447703

Completed Knowledge-focused Sponsor: Thomas Jefferson University Source: ClinicalTrials.gov ↗

First seen Dec 10, 2025 · Last updated Apr 25, 2026 · Updated 18 times

Summary

This study tested a mobile-friendly tool that helps men with prostate cancer learn about genetic testing and decide if they want it. Researchers compared the tool to traditional genetic counseling. The goal was to see if the tool could help patients make informed choices. The study included 346 men with advanced or high-risk prostate cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE IV PROSTATE CANCER AJCC V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Associated Medical Professions of New York

Syracuse, New York, 13210, United States
New York University- Langone Health

New York, New York, 10016, United States
Sidney Kimmel Cancer Center at Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States
University of Washington/ SCCA

Seattle, Washington, 98109, United States
VA New York Harbor Health System- Manhattan Campus

New York, New York, 10010, United States

Conditions

Explore the condition pages connected to this study.

BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA METASTATIC PROSTATE CARCINOMA STAGE IIIB PROSTATE CANCER AJCC V8 STAGE IIIC PROSTATE CANCER AJCC V8 STAGE IV PROSTATE CANCER AJCC V8